Definitive Contract HHSD200201792734C
Award Date
12/23/16
Potential Completion Date
2/28/18
Potential Value
$45M
Federal Agency
CDC Pittsburgh
Awardee
Seqirus USA Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Centers for Disease Control and Prevention (CDC), an agency within the U.S. Department of Health and Human Services, to Seqirus USA Inc. through its Seqirus Usa, Inc. Division. The contract, valued at $23,480,000.00, is for the delivery of ADULT FLU vaccines. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and the Ultimate Completion Date is February 28, 2019. The contract is not designated as a set-aside. Seqirus USA Inc. is a...
This is a $58,485,000.00 definitive, firm-fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) on December 23, 2016 to Seqirus USA Inc. through its Seqirus Usa, Inc. division. The contract is for the delivery of pediatric influenza vaccines, with a period of performance ending on February 28, 2018. Seqirus USA Inc. is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal...
This is a firm-fixed-price delivery order awarded by the Veterans Integrated Service Network 21 (VISN 21) of the Department of Veterans Affairs (VA) to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The $97,923 contract is for the supply of flu vaccines, with an ultimate completion date of October 31, 2018. Seqirus USA Inc. is known for producing a range of influenza vaccine formulations, including quadrivalent vaccines, multi-dose vials, and pre-filled...
This is a $94,800.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Seqirus USA Inc. for the supply of influenza virus vaccines. The contract has no set-aside designation. Seqirus USA Inc. is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies, including the Department of Defense, Department of Veterans Affairs, Department of Health and...
This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine production. The $188,700.00 contract is for the delivery of flu vaccines, with an ultimate completion date of October 15, 2016. The contract is not a set-aside award. Seqirus is a foreign-owned, for-profit organization that has been awarded numerous federal contracts to supply influenza vaccines to various...
This is a $91,950.00 firm-fixed-price delivery order awarded by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs (VA) to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine production. The contract is for the delivery of flu vaccine, with a performance period ending on February 27, 2019. This award is not associated with a set-aside program, and no subcontractors are mentioned. Seqirus USA Inc. is a foreign-owned,...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Seqirus USA Inc., a global biotechnology company, for the provision of flu vaccines. The contract has a potential value of $138,880.00 and a completion date of October 31, 2018. Seqirus USA Inc., the prime contractor, is a foreign-owned, for-profit organization that manufactures influenza vaccines. The company has previously received contracts from various...
This federal contract award, SPE2DP16M0735, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The $124,772.50 firm-fixed-price purchase order is for the delivery of influenza virus vaccines, with an ultimate completion date of October 3, 2016. The contract does not have a set-aside designation. Seqirus USA Inc., through its Seqirus Usa, Inc. division, is known for producing a...
The U.S. federal government has awarded a $141,185 delivery order contract to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The contract, with a performance period ending on August 30, 2024, is for the supply of influenza virus vaccines. Seqirus USA Inc. is the prime contractor and will be delivering the vaccines under this firm-fixed-price contract. This award is not associated with a set-aside program. Seqirus USA...
This federal contract award to Seqirus USA Inc. is for the delivery of flu vaccines. The $1,241,993.00 fixed-price purchase order was awarded on June 30, 2020 by the U.S. Department of Health and Human Services and has a completion date of July 30, 2020. Seqirus is a global biotechnology company that specializes in the manufacturing and delivery of influenza vaccines to various federal government agencies. The company has been awarded multiple Indefinite Delivery Contracts (IDCs) with agencies...